Axios International was founded 1997 to advance health care in developing countries. We are specialists in healthcare systems with a focus on chronic disease management and drug delivery integrating local resources and priorities.

Our originality resides in how and with whom we work.

• Our Aim is to understand where the system is broken and create tools to fix it.
• Our work process has three phases. 
  • We invent new, integrated approaches,
  • We verify these approaches, and
  • We facilitate large-scale roll-out.
• Our Mission is to mobilize the private sector through partnerships. Our clients' programs must improve outcomes for the greatest number of people.
• Our Signature is

  Pioneering healthcare solutions in developing countries

Focus

HIV/AIDS and cancer are two of our specialties, but not just because of the challenges they pose. HIV/AIDS and cancer share the fact that the advent of treatment has converted them from deadly to chronic diseases.

Unfortunately, healthcare delivery in developing countries is generally not organized to manage chronic patients. Our systems approach addresses this gap to better the conditions of care for all patients.

LOCATIONS

Axios offices are located in Dublin, Ireland; Paris, France; Durban, South Africa; Kampala, Uganda; Beijing, China. Axios works closely on several drug donation programs with Axios Healthcare Development (AHD), a US 501(c)3 organization with offices in Cleveland, Ohio; Dar es Salaam, Tanzania; Abuja, Nigeria and Addis Ababa, Ethiopia.

CORPORATE MANAGEMENT

• CEO, Dr. Joseph Saba, MD, Paris
• CTO, Anne Reeler, PhD, Paris
• CFO, John MacDonald, MA, ACMA, Dublin
• VP Operations, Sowedi Muyingo, BSPharm, MBA, Kampala
• President, Axios Foundation, Peter Ahern, MSc, Cleveland

AXIOS SERVICES

What does Axios do for our clients?

• Design and implement a philanthropy program
• Develop and implement a model for large-scale execution in the field
• Provide full management services for medical product Access and Donation programs
• Define and execute field research to orient health policy, evaluate an existing program or provide specialized data analysis

Examples

• Design and Implementation of a national Tertiary Care program in Tanzania, including extensive management and operations renovation of a national teaching hospital and creation of a referral system (Abbott Laboratories Fund)
• Integration and scale-up of Voluntary Counseling and Testing within the health delivery system in Tanzania and Burkina Faso (Abbott Laboratories Fund)
• Improvement of Prevention of Mother-to-Child Transmission programs through integration of traditional birth attendants in Tanzania (Elizabeth Glaser Pediatric Aids Foundation)
• Management of Donation and Access programs including selection of institutions, forecasting, logistics, information systems, (Abbott Laboratories, Boehringer Ingelheim GmbH, Novartis Pharmaceuticals, Pfizer Inc)
  • Creation of AccessToTreatment.org network, offering one stop service to 450 healthcare institutions in 116 countries, for the above-mentioned programs. 8 million persons served to-date
• Field and Statistical Research to evaluate:
  • Scaling up techniques for PMTCT
  • Impact of Diflucan Donation Programs on care
  • Health economics of HIV treatment models
  • Trends for Accelerating Access Initiative